Recombinant CEACAM5 & CD3E (Cibisatamab Biosimilar) antibody
This Human Monoclonal antibody specifically detects CEACAM5 & CD3E (Cibisatamab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538087
$323.13
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CEACAM5 & CD3E (Cibisatamab Biosimilar) antibody (ABIN7538087)
Target
CEACAM5 & CD3E (Cibisatamab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Cibisatamab Biosimilar – Anti-CEACAM5 & CD3E mAb - Research Grade
-
Characteristics
- Antibody Type: Bispecific mAb with Domain Crossover
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa, IgG1 lambda
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CEACAM5 & CD3E (Cibisatamab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Cibisatamab (CEA-TCB), a T cell bispecific antibody, binds Carcino-Embryonic Antigen (CEA) on cancer cells and CD3 on T cells. Cibisatamab (CEA-TCB) triggers T cell killing of cancer cell lines expressing moderate to high levels of CEA at the cell surface. Cibisatamab (CEA-TCB) can be used for colorectal cancer research.
-
CAS-No
- 1855925-27-7
Target
-
You are here:
